Xtant Medical Holdings (XTNT) Profit After Tax Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.78% |
| Sep 30, 2025 | 24.25% |
| Jun 30, 2025 | 28.04% |
| Mar 31, 2025 | 15.14% |
| Dec 31, 2024 | -14.55% |
| Sep 30, 2024 | -21.74% |
| Jun 30, 2024 | -14.77% |
| Mar 31, 2024 | -9.47% |
| Dec 31, 2023 | 40.29% |
| Sep 30, 2023 | 37.57% |
| Jun 30, 2023 | 15.23% |
| Mar 31, 2023 | 16.93% |
| Dec 31, 2022 | 40.00% |
| Sep 30, 2022 | 22.68% |
| Jun 30, 2022 | 29.32% |
| Mar 31, 2022 | 17.48% |
| Dec 31, 2021 | 12.83% |
| Sep 30, 2021 | 18.11% |
| Jun 30, 2021 | 30.32% |
| Mar 31, 2021 | 65.09% |
| Dec 31, 2020 | -15.56% |
| Sep 30, 2020 | 27.28% |
| Jun 30, 2020 | 3.18% |
| Mar 31, 2020 | 9.81% |
| Dec 31, 2019 | 13.44% |
| Sep 30, 2019 | -10.02% |
| Jun 30, 2019 | -0.40% |
| Mar 31, 2019 | 7.53% |
| Dec 31, 2018 | -68.58% |
| Sep 30, 2018 | 6.35% |
| Jun 30, 2018 | -15.04% |
| Mar 31, 2018 | -25.77% |
| Dec 31, 2017 | -42.26% |
| Sep 30, 2017 | -27.58% |
| Jun 30, 2017 | -72.49% |
| Mar 31, 2017 | -40.76% |
| Dec 31, 2016 | -0.83% |
| Sep 30, 2016 | -9.13% |
| Jun 30, 2016 | -61.57% |
| Mar 31, 2016 | -25.70% |
| Dec 31, 2015 | 30.06% |
| Sep 30, 2015 | 5.85% |
| Jun 30, 2015 | -7.14% |